This site uses third parties to own and optimize your navigation and perform analytical work cookies. If you continue browsing, consider that you accept its use.
You can learn more at our Cookie Policy.


Functional GPCR Screening

INNOPROT has developed a proprietary drug discovery technology platform for multiplexing GPCR screening. This technology called Nomad allows the measurement in vitro of the different signalling pathways involving each GPCR activation in living cells.
This is the simplest way to identify GPCR biased ligands.

Endpoints analyzed with Nomad technology:
Endpoints are measured on the same engineered cell line over-expressing the label-free GPCR.

Learn more about NOMAD Biosensors.

If you are interested in a GPCR screening service, customized cell line development using this new technology, please contact us at innoprot@innoprot.com


© Innoprot 2008 - Cell Based Assays for Drug Discovery Screening - Cookie Policy